Search
Search
Close this search box.

Canada’s Adult-Use Cannabis Sales Fall 11% In January, As Annual Growth Continues To Slow

Cannabis sales in Canada dropped to their lowest level in nearly a year in January, according to the latest figures from Statistics Canada.

Adult-use cannabis sales fell by over 11% to C$400.1m in January 2024, down from C$451.8m in December 2023, though this figure was revised upwards from $441.2m.

Compared to January 2023, sales grew by just 1.2%, marking a significant fall in year-on-year growth compared to the 14.1% seen between January 2022 and 2023.

Last year also saw the steepest decline in annual sales since legalization in 2018, falling for three consecutive months after a high point in August 2023, before recovering in December.

Between August and November 2023, retail sales fell 12% from C$467m to C$407.9m, although sales for the year still saw marginal growth, increasing to C$5.08bn from C$5.07bn.

The number of adult-use cannabis stores also declined in January, dropping from 562 to 498, the lowest number seen since April 2023.

The number of retail stores across Canada also declined. As of March 2024, there were 3,690 (up from 3,682 in January) cannabis stores in Canada, excluding provincial online stores.

It comes as a number of key changes to Canada’s Cannabis Act have been proposed as part of a long-running review into cannabis legalisation.

As Business of Cannabis reported on Friday, this includes changes to the excise tax burden, and could allow cultivators to sell directly to consumers.

⏰ Pre-order discount ends Jan 15
-- Days
-- Hours
-- Mins
Data packs delivered January 2026
🔬 New Report Due January 2026

Global Medical Cannabis Market Review 2026

A comprehensive analysis of the international medical cannabis supply chain — examining country-specific data on exports, imports, market size, domestic production, and distribution landscapes. Understand the driving forces behind global supply dynamics, the impact of telemedicine on patient access, and regulatory changes shaping the market.

What's covered

  • 📊 Global supply chain overview — understand export/import dynamics and domestic production capabilities
  • 🌍 8 export country snapshots — Canada, Portugal, Denmark, North Macedonia, Spain, Australia, Czech Republic, South Africa
  • 👥 6 patient market snapshots — Australia, Germany, UK, Poland, Brazil, France
  • 🔮 Key themes — Canada's global impact, telemedicine growth, new market openings, quota changes
Export Markets
🇨🇦 Canada 🇵🇹 Portugal 🇩🇰 Denmark 🇲🇰 N. Macedonia 🇪🇸 Spain 🇦🇺 Australia 🇨🇿 Czechia 🇿🇦 South Africa
Patient Markets
🇦🇺 Australia 🇩🇪 Germany 🇬🇧 UK 🇵🇱 Poland 🇧🇷 Brazil 🇫🇷 France
100% free • No credit card required
As trusted by
DIAGEO KPMG Coca-Cola BARCLAYS BNP PARIBAS AB InBev NOVARTIS Johnson & Johnson PEPSICO AXA POLITICO Bloomberg amazon CNN Business
Part of our annual market review series GDPR compliant

Related Posts

Related Posts

CONNECT

Related Posts

Related Posts

Recent Posts

Related Posts

Subscribe to our mailing list to receives daily updates!

We won’t spam you

Categories

Browse by Tags

CATEGORIES

EDITION

BUSINESS OF CANNABIS

© 2023 Prohibition Holdings Ltd. All Rights Reserved.

EDITION

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?